Search results
Results From The WOW.Com Content Network
Aside from individual reported experiences, there has been a limited amount of published work summarising salvia divinorum effects. A survey of salvia users found that 38% described the effects as unique in comparison to other methods of altering consciousness. 23% said the effects were like yoga, meditation or trance. [76]
Poison ivy. What it looks like: Poison ivy is a type of allergic contact dermatitis that is caused by the oil (urushiol oil) in the poison ivy plant, explains Karan Lal, D.O., M.S., F.A.A.D ...
Saliva nitric test strip (Berkeley Test) showing colored scale of nitric oxide status – See article and jump to Cardiovascular Disease, Nitric Oxide: a salivary biomarker for cardio-protection Saliva testing or Salivaomics is a diagnostic technique that involves laboratory analysis of saliva to identify markers of endocrine , immunologic ...
Salvinorin A is the main active psychotropic molecule in Salvia divinorum.Salvinorin A is considered a dissociative hallucinogen. [3] [4]It is structurally distinct from other naturally occurring hallucinogens (such as DMT, psilocybin, and mescaline) because it contains no nitrogen atoms; hence, it is not an alkaloid (and cannot be rendered as a salt), but rather is a terpenoid. [3]
Skin and skin structure infections (SSSIs), also referred to as skin and soft tissue infections (SSTIs), [1] or acute bacterial skin and skin structure infections (ABSSSIs), [2] are infections of skin and associated soft tissues (such as loose connective tissue and mucous membranes).
A drug test (also often toxicology screen or tox screen) is a technical analysis of a biological specimen, for example urine, hair, blood, breath, sweat, or oral fluid/saliva—to determine the presence or absence of specified parent drugs or their metabolites.
35. Salvia divinorum, except for any drug product approved by the United States Food and Drug Administration which contains Salvia divinorum or its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, if the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation.
For individuals developing AGEP while taking multiple drugs, non-essential drugs should be discontinued and essential drugs should be replaced by chemically unrelated drugs that are used as alternatives to the discontinued drug(s). In cases of multiple drug intake, skin and/or in vitro testing may be of some use in identifying the offending drug.